X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (150) 150
male (95) 95
female (90) 90
middle aged (79) 79
aged (71) 71
risk factors (63) 63
diabetes (55) 55
medicine, general & internal (53) 53
cardiac & cardiovascular systems (49) 49
clinical trials (46) 46
cholesterol (43) 43
cardiovascular disease (40) 40
treatment outcome (40) 40
abridged index medicus (38) 38
type 2 diabetes (38) 38
risk (37) 37
analysis (36) 36
double-blind method (36) 36
endocrinology & metabolism (35) 35
adult (34) 34
cardiovascular diseases (32) 32
fenofibrate (32) 32
prevention (31) 31
research (31) 31
medical research (30) 30
mortality (30) 30
statins (29) 29
diabetes mellitus (28) 28
drug therapy (28) 28
therapy (28) 28
fenofibrate - therapeutic use (27) 27
hypolipidemic agents - therapeutic use (26) 26
statistics, epidemiology and research design (25) 25
diabetes mellitus, type 2 - complications (23) 23
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (23) 23
diabetes mellitus, type 2 - drug therapy (22) 22
randomized controlled trials as topic (22) 22
cholesterol, ldl - blood (21) 21
coronary-heart-disease (21) 21
disease (21) 21
lipids (21) 21
myocardial-infarction (21) 21
atherosclerosis (20) 20
health aspects (20) 20
patients (20) 20
risk assessment (20) 20
anticholesteremic agents - therapeutic use (19) 19
cardiovascular diseases - prevention & control (19) 19
peripheral vascular disease (19) 19
internal medicine (18) 18
metaanalysis (18) 18
care and treatment (17) 17
fibric acids (17) 17
heart attacks (17) 17
medicine, experimental (17) 17
mellitus (17) 17
cardiovascular (16) 16
events (16) 16
follow-up studies (16) 16
lipoproteins (16) 16
low density lipoproteins (16) 16
statin therapy (16) 16
time factors (16) 16
australia (15) 15
cardiovascular-disease (15) 15
research design (15) 15
coronary heart disease (14) 14
evidence-based medicine (14) 14
outcomes (14) 14
patient selection (14) 14
biomarkers - blood (13) 13
pravastatin - therapeutic use (13) 13
prospective studies (13) 13
cardiovascular diseases - epidemiology (12) 12
cardiovascular events (12) 12
cholesterol, hdl - blood (12) 12
incidence (12) 12
insulin (12) 12
management (12) 12
metabolism (12) 12
proportional hazards models (12) 12
risk-factors (12) 12
usage (12) 12
animals (11) 11
association (11) 11
atorvastatin (11) 11
australia - epidemiology (11) 11
cardiovascular diseases - drug therapy (11) 11
diabetes mellitus, type 2 - blood (11) 11
diabetic retinopathy (11) 11
dosage and administration (11) 11
glucose (11) 11
health risk assessment (11) 11
human (11) 11
information science (11) 11
insulin resistance (11) 11
multivariate analysis (11) 11
pravastatin (11) 11
reduction (11) 11
stroke (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
The American heart journal, ISSN 0002-8703, 2016, Volume 173, pp. 94 - 101
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2015.11.015 Byline: Marc S. Sabatine, Robert P. Giugliano, Anthony Keech, Narimon Honarpour, Huei Wang, Thomas Liu, Scott M... 
Cardiovascular | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | EVOLOCUMAB AMG 145 | STATIN THERAPY | LDL-C | LOW-DENSITY-LIPOPROTEIN | PRIMARY-PREVENTION TRIAL | MONOCLONAL-ANTIBODY | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | United States - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Incidence | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Cholesterol, VLDL - drug effects | Injections, Subcutaneous | Lipoproteins, LDL - drug effects | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Female | Serine Endopeptidases | Drug Therapy, Combination | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Risk Factors | Treatment Outcome | Cholesterol, VLDL - blood | Australia - epidemiology | Antibodies, Monoclonal - administration & dosage | Norway - epidemiology | United Kingdom - epidemiology | Lipoproteins, LDL - blood | Proprotein Convertase 9 | Monoclonal antibodies | Blood circulation disorders | Low density lipoproteins | Risk factors | Vascular diseases | Clinical trials | Cardiovascular disease | Lipids | Cardiovascular diseases | Low density lipoprotein | Statins | Morbidity
Journal Article
by Swerdlow, Daniel I and Preiss, David and Kuchenbaecker, Karoline B and Holmes, Michael V and Engmann, Jorgen E L and Shah, Tina and Sofat, Reecha and Stender, Stefan and Johnson, Paul C D and Scott, Robert A and Leusink, Maarten and Verweij, Niek and Sharp, Stephen J and Guo, Yiran and Giambartolomei, Claudia and Chung, Christina and Peasey, Anne and Amuzu, Antoinette and Li, KaWah and Palmen, Jutta and Howard, Philip and Cooper, Jackie A and Drenos, Fotios and Li, Yun R and Lowe, Gordon and Gallacher, John and Stewart, Marlene C W and Tzoulaki, Ioanna and Buxbaum, Sarah G and van der A, Daphne L and Forouhi, Nita G and Onland-Moret, N Charlotte and van der Schouw, Yvonne T and Schnabel, Renate B and Hubacek, Jaroslav A and Kubinova, Ruzena and Baceviciene, Migle and Tamosiunas, Abdonas and Pajak, Andrzej and Topor-Madry, Romanvan and Stepaniak, Urszula and Malyutina, Sofia and Baldassarre, Damiano and Sennblad, Bengt and Tremoli, Elena and de Faire, Ulf and Veglia, Fabrizio and Ford, Ian and Jukema, J Wouter and Westendorp, Rudi G J and de Borst, Gert Jan and de Jong, Pim A and Algra, Ale and Spiering, Wilko and der Zee, Anke H Maitland-van and Klungel, Olaf H and de Boer, Anthonius and Doevendans, Pieter A and Eaton, Charles B and Robinson, Jennifer G and Duggan, David and Kjekshus, John and Downs, John R and Gotto, Antonio M and Keech, Anthony C and Marchioli, Roberto and Tognoni, Gianni and Sever, Peter S and Poulter, Neil R and Waters, David D and Pedersen, Terje R and Amarenco, Pierre and Nakamura, Haruo and McMurray, John J V and Lewsey, James D and Chasman, Daniel I and Ridker, Paul M and Maggioni, Aldo P and Tavazzi, Luigi and Ray, Kausik K and Seshasai, Sreenivasa Rao Kondapally and Manson, JoAnn E and Price, Jackie F and Whincup, Peter H and Morris, Richard W and Lawlor, Debbie A and Smith, George Davey and Ben-Shlomo, Yoav and Schreiner, Pamela J and Fornage, Myriam and Siscovick, David S and Cushman, Mary and Kumari, Meena and Wareham, Nick J and Verschuren, W M Monique and Redline, Susan and Patel, Sanjay R and Whittaker, John C and Hamsten, Anders and Delaney, Joseph A and ... and DIAGRAM Consortium, MAGIC Consortium, InterAct Consortium and MAGIC Consortium and InterAct Consortium and DIAGRAM Consortium
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9965, pp. 351 - 361
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9677, pp. 1780 - 1788
Journal Article
by Fulcher, Jordan and O'Connell, Rachel and Voysey, Merryn and Emberson, Jonathan and Blackwell, Lisa and Mihaylova, Borislava and Simes, John and Collins, Rory and Kirby, Adrienne and Colhoun, Helen and Braunwald, Eugene and La Rosa, John and Pedersen, T.R and Tonkin, Andrew and Davis, Barry and Sleight, Peter and Franzosi, Maria Grazia and Baigent, Colin and Keech, Anthony and De Lemos, J and Braunwald, E and Blazing, M and Murphy, S and Downs, J.R and Gotto, A and Clearfield, M and Holdaas, H and Gordon, D and Davis, B and Koren, M and Dahlöf, B and Poulter, N and Sever, P and Knopp, R.H and Fellström, B and Holdaas, H and Jardine, A and Schmieder, R and Zannad, F and Goldbourt, U and Kaplinsky, E and Colhoun, H.M and Betteridge, D.J and Durrington, P.N and Hitman, G.A and Fuller, J and Neil, A and Wanner, C and Krane, V and Sacks, F and Moyé, L and Pfeffer, M and Hawkins, C.M and Braunwald, E and Kjekshus, J and Wedel, H and Wikstrand, J and Barter, P and Tavazzi, L and Maggioni, A and Marchioli, R and Tognoni, G and Franzosi, M.G and Maggioni, A and Bloomfield, H and Robins, S and Collins, R and Armitage, J and Parish, S and Peto, R and Sleight, P and Pedersen, T.R and Ridker, P.M and Holman, R and Meade, T and Simes, J and MacMahon, S and Marschner, I and Tonkin, A and Shaw, J and Serruys, P.W and Nakamura, H and Knatterud, G and Furberg, C and Byington, R and Macfarlane, P and Cobbe, S and Ford, I and Murphy, M and Blauw, G.J and Packard, C and Shepherd, J and Kjekshus, J and Pedersen, T and Wilhelmsen, L and Braunwald, E and Cannon, C and Murphy, S and Collins, R and Armitage, J and ... and unav and Cholesterol Treatment Trialists' (CTT) Collaboration and Cholesterol Treatment Trialists' C
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9976, pp. 1397 - 1405
Journal Article
Diabetes care, ISSN 1935-5548, 2015, Volume 38, Issue 3, pp. 521 - 528
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 12, pp. 1107 - 1117
Journal Article
Journal Article